← Leaderboards
Anda M Vlad
Magee-Women'S Res Inst And Foundation
$2,135,923
Attributed
$2,842,418
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $497.8K · FY2012–22$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,842,418 · 2
By mechanism
R01$2,842,418 · 2
Top collaborators
- Ronald J Buckanovich5 shared
Most similar at Magee-Women'S Res Inst And Foundation
Same institution · by research overlap
- Ronald J Buckanovich$14,686,030
- Sandra Cascio$1,600,259
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorCellsTherapeutic TargetImmuneOvarian NeoplasmImmunotherapyMalignant Neoplasm Of OvaryInflammatoryResponseT-LymphocyteLinkImmunobiologyIn VivoIn VitroVaccinesInflammationTumor AntigensRegulatory T-LymphocyteTransgenic MiceMucin 1 ProteinInhibitor/AntagonistMortalityNovel TherapeuticsAldehyde Dehydrogenases
Grant awards (10)
ALDH Inhibition as Modulator of Tumor Immunobiology$431,843
R01 · FY2022 · CA
ALDH Inhibition as Modulator of Tumor Immunobiology$14,478
R01 · FY2022 · CA
ALDH Inhibition as Modulator of Tumor Immunobiology$437,359
R01 · FY2021 · CA
ALDH Inhibition as Modulator of Tumor Immunobiology$60,414
R01 · FY2021 · CA
ALDH Inhibition as Modulator of Tumor Immunobiology$468,896
R01 · FY2020 · CA
MUC1 Roles in ovarian cancer pathogenesis and immune therapy$287,489
R01 · FY2016 · CA · contact PI
MUC1 Roles in ovarian cancer pathogenesis and immune therapy$287,764
R01 · FY2015 · CA · contact PI
MUC1 Roles in ovarian cancer pathogenesis and immune therapy$279,390
R01 · FY2014 · CA · contact PI
MUC1 Roles in ovarian cancer pathogenesis and immune therapy$271,239
R01 · FY2013 · CA · contact PI
MUC1 Roles in ovarian cancer pathogenesis and immune therapy$303,546
R01 · FY2012 · CA · contact PI